Logo image of CRAYN.OL

CRAYON GROUP HOLDING AS (CRAYN.OL) Stock Fundamental Analysis

OSL:CRAYN - Euronext Oslo - NO0010808892 - Common Stock - Currency: NOK

142.4  +4 (+2.89%)

Fundamental Rating

5

CRAYN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Software industry. While CRAYN has a great profitability rating, there are quite some concerns on its financial health. CRAYN may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRAYN was profitable.
In the past year CRAYN had a positive cash flow from operations.
CRAYN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CRAYN had a positive operating cash flow.
CRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFCRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.53%, CRAYN is in line with its industry, outperforming 50.49% of the companies in the same industry.
CRAYN has a better Return On Equity (10.80%) than 63.37% of its industry peers.
CRAYN's Return On Invested Capital of 11.88% is amongst the best of the industry. CRAYN outperforms 83.17% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRAYN is below the industry average of 10.99%.
The last Return On Invested Capital (11.88%) for CRAYN is above the 3 year average (8.15%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.53%
ROE 10.8%
ROIC 11.88%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
CRAYN.OL Yearly ROA, ROE, ROICCRAYN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

CRAYN has a Profit Margin (4.12%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CRAYN has declined.
The Operating Margin of CRAYN (11.00%) is better than 61.39% of its industry peers.
In the last couple of years the Operating Margin of CRAYN has grown nicely.
With an excellent Gross Margin value of 89.27%, CRAYN belongs to the best of the industry, outperforming 89.11% of the companies in the same industry.
CRAYN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11%
PM (TTM) 4.12%
GM 89.27%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
CRAYN.OL Yearly Profit, Operating, Gross MarginsCRAYN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

CRAYN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CRAYN has been increased compared to 1 year ago.
Compared to 5 years ago, CRAYN has more shares outstanding
Compared to 1 year ago, CRAYN has an improved debt to assets ratio.
CRAYN.OL Yearly Shares OutstandingCRAYN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRAYN.OL Yearly Total Debt VS Total AssetsCRAYN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.00, we must say that CRAYN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.00, CRAYN is doing worse than 68.32% of the companies in the same industry.
CRAYN has a debt to FCF ratio of 1.61. This is a very positive value and a sign of high solvency as it would only need 1.61 years to pay back of all of its debts.
CRAYN's Debt to FCF ratio of 1.61 is fine compared to the rest of the industry. CRAYN outperforms 73.27% of its industry peers.
CRAYN has a Debt/Equity ratio of 0.58. This is a neutral value indicating CRAYN is somewhat dependend on debt financing.
CRAYN has a worse Debt to Equity ratio (0.58) than 65.35% of its industry peers.
Even though the debt/equity ratio score it not favorable for CRAYN, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 1.61
Altman-Z 1
ROIC/WACC1.2
WACC9.92%
CRAYN.OL Yearly LT Debt VS Equity VS FCFCRAYN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

CRAYN has a Current Ratio of 0.98. This is a bad value and indicates that CRAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
CRAYN has a Current ratio of 0.98. This is in the lower half of the industry: CRAYN underperforms 68.32% of its industry peers.
A Quick Ratio of 0.98 indicates that CRAYN may have some problems paying its short term obligations.
With a Quick ratio value of 0.98, CRAYN is not doing good in the industry: 67.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
CRAYN.OL Yearly Current Assets VS Current LiabilitesCRAYN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

CRAYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.17%, which is quite impressive.
CRAYN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
CRAYN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.67%.
CRAYN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.43% yearly.
EPS 1Y (TTM)44.17%
EPS 3Y8.95%
EPS 5YN/A
EPS Q2Q%38.61%
Revenue 1Y (TTM)7.67%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%6.61%

3.2 Future

The Earnings Per Share is expected to grow by 48.55% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -1.25% on average over the next years.
EPS Next Y108.12%
EPS Next 2Y65.95%
EPS Next 3Y48.55%
EPS Next 5YN/A
Revenue Next Year13.29%
Revenue Next 2Y13.92%
Revenue Next 3Y13.37%
Revenue Next 5Y-1.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRAYN.OL Yearly Revenue VS EstimatesCRAYN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CRAYN.OL Yearly EPS VS EstimatesCRAYN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 34.90, which means the current valuation is very expensive for CRAYN.
Based on the Price/Earnings ratio, CRAYN is valued a bit cheaper than the industry average as 70.30% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.25. CRAYN is valued slightly more expensive when compared to this.
CRAYN is valuated correctly with a Price/Forward Earnings ratio of 13.34.
88.12% of the companies in the same industry are more expensive than CRAYN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, CRAYN is valued a bit cheaper.
Industry RankSector Rank
PE 34.9
Fwd PE 13.34
CRAYN.OL Price Earnings VS Forward Price EarningsCRAYN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRAYN is valued a bit cheaper than 72.28% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CRAYN is valued cheaply inside the industry as 88.12% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.1
EV/EBITDA 11.35
CRAYN.OL Per share dataCRAYN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRAYN may justify a higher PE ratio.
A more expensive valuation may be justified as CRAYN's earnings are expected to grow with 48.55% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y65.95%
EPS Next 3Y48.55%

0

5. Dividend

5.1 Amount

No dividends for CRAYN!.
Industry RankSector Rank
Dividend Yield N/A

CRAYON GROUP HOLDING AS

OSL:CRAYN (5/30/2025, 7:00:00 PM)

142.4

+4 (+2.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-27 2025-08-27
Inst Owners63.5%
Inst Owner ChangeN/A
Ins Owners0.82%
Ins Owner ChangeN/A
Market Cap12.75B
Analysts82.67
Price Target143.67 (0.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.25%
Min EPS beat(2)-60.61%
Max EPS beat(2)-37.9%
EPS beat(4)0
Avg EPS beat(4)-35.83%
Min EPS beat(4)-60.61%
Max EPS beat(4)-13.94%
EPS beat(8)2
Avg EPS beat(8)-24.98%
EPS beat(12)2
Avg EPS beat(12)-66.98%
EPS beat(16)5
Avg EPS beat(16)-94.94%
Revenue beat(2)0
Avg Revenue beat(2)-8.54%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)-7.25%
Revenue beat(4)0
Avg Revenue beat(4)-7.68%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)-4.06%
Revenue beat(8)3
Avg Revenue beat(8)-3.98%
Revenue beat(12)5
Avg Revenue beat(12)-13.42%
Revenue beat(16)5
Avg Revenue beat(16)-31.36%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)1.05%
EPS NQ rev (3m)-5.39%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.39%
Revenue NQ rev (1m)-1.93%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE 34.9
Fwd PE 13.34
P/S 1.79
P/FCF 11.1
P/OCF 9.64
P/B 4.7
P/tB N/A
EV/EBITDA 11.35
EPS(TTM)4.08
EY2.87%
EPS(NY)10.68
Fwd EY7.5%
FCF(TTM)12.83
FCFY9.01%
OCF(TTM)14.77
OCFY10.37%
SpS79.49
BVpS30.28
TBVpS-11.43
PEG (NY)0.32
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.53%
ROE 10.8%
ROCE 17.55%
ROIC 11.88%
ROICexc 17.65%
ROICexgc N/A
OM 11%
PM (TTM) 4.12%
GM 89.27%
FCFM 16.14%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
ROICexc(3y)11.91%
ROICexc(5y)28.33%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.05%
ROCE(5y)12.29%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y22.85%
ROICexc growth 5Y8.87%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 1.61
Debt/EBITDA 1.4
Cap/Depr 50.58%
Cap/Sales 2.44%
Interest Coverage 250
Cash Conversion 117.39%
Profit Quality 392.15%
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 1
F-Score6
WACC9.92%
ROIC/WACC1.2
Cap/Depr(3y)45.9%
Cap/Depr(5y)48.63%
Cap/Sales(3y)2.42%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.17%
EPS 3Y8.95%
EPS 5YN/A
EPS Q2Q%38.61%
EPS Next Y108.12%
EPS Next 2Y65.95%
EPS Next 3Y48.55%
EPS Next 5YN/A
Revenue 1Y (TTM)7.67%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%6.61%
Revenue Next Year13.29%
Revenue Next 2Y13.92%
Revenue Next 3Y13.37%
Revenue Next 5Y-1.25%
EBIT growth 1Y72.09%
EBIT growth 3Y24.41%
EBIT growth 5Y42.57%
EBIT Next Year56.93%
EBIT Next 3Y29.1%
EBIT Next 5YN/A
FCF growth 1Y231.56%
FCF growth 3YN/A
FCF growth 5Y59.47%
OCF growth 1Y165.01%
OCF growth 3Y272.45%
OCF growth 5Y47.49%